首页> 美国卫生研究院文献>Antibiotics >Point Prevalence Survey of Antibiotic Use across 13 Hospitals in Uganda
【2h】

Point Prevalence Survey of Antibiotic Use across 13 Hospitals in Uganda

机译:乌干达 13 家医院抗生素使用的点流行率调查

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Standardized monitoring of antibiotic use underpins the effective implementation of antimicrobial stewardship interventions in combatting antimicrobial resistance (AMR). To date, few studies have assessed antibiotic use in hospitals in Uganda to identify gaps that require intervention. This study applied the World Health Organization’s standardized point prevalence survey methodology to assess antibiotic use in 13 public and private not-for-profit hospitals across the country. Data for 1077 patients and 1387 prescriptions were collected between December 2020 and April 2021 and analyzed to understand the characteristics of antibiotic use and the prevalence of the types of antibiotics to assess compliance with Uganda Clinical Guidelines; and classify antibiotics according to the WHO Access, Watch, and Reserve classification. This study found that 74% of patients were on one or more antibiotics. Compliance with Uganda Clinical Guidelines was low (30%); Watch-classified antibiotics were used to a high degree (44% of prescriptions), mainly driven by the wide use of ceftriaxone, which was the most frequently used antibiotic (37% of prescriptions). The results of this study identify key areas for the improvement of antimicrobial stewardship in Uganda and are important benchmarks for future evaluations.
机译:抗生素使用的标准化监测是有效实施抗菌素管理干预措施以对抗抗菌素耐药性 (AMR) 的基础。迄今为止,很少有研究评估乌干达医院的抗生素使用情况以确定需要干预的差距。本研究应用世界卫生组织的标准化点流行率调查方法评估了全国 13 家公立和私立非营利医院的抗生素使用情况。在 2020 年 12 月至 2021 年 4 月期间收集了 1077 名患者和 1387 份处方的数据,并进行了分析,以了解抗生素使用的特点和抗生素类型的流行率,以评估对乌干达临床指南的依从性;并根据 WHO Access、Watch 和 Reserve 分类对抗生素进行分类。这项研究发现 74% 的患者正在服用一种或多种抗生素。对乌干达临床指南的依从性低 (30%);手表分类的抗生素使用率很高(占处方的 44%),主要是由于头孢曲松的广泛使用,这是最常用的抗生素(占处方的 37%)。本研究的结果确定了乌干达改善抗菌药物管理的关键领域,是未来评估的重要基准。

著录项

代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号